Literature DB >> 33922820

Role of MicroRNAs in Human Osteosarcoma: Future Perspectives.

Lola Llobat1, Olivia Gourbault2.   

Abstract

Osteosarcoma (OS) is a rare form of cancer with high death rate but is one of the most frequent forms of bone cancer in children and adolescents. MiRNAs are small endogenous RNAs that regulate gene expression post-transcriptionally. The discovery of miRNAs could allow us to obtain an earlier diagnosis, predict prognosis and chemoresistance, and lead to the discovery of new treatments in different types of tumors, including OS. Despite the fact that there is currently only one clinical trial being carried out on a single miRNA for solid tumors, it is very probable that the number of clinical trials including miRNAs as prognostic and diagnostic biomarkers, as well as potential therapeutic targets, will increase in the near future. This review summarizes the different miRNAs related to OS and their possible therapeutic application.

Entities:  

Keywords:  biomarkers; human osteosarcoma; human sarcoma; molecular oncology

Year:  2021        PMID: 33922820     DOI: 10.3390/biomedicines9050463

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  122 in total

1.  Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.

Authors:  Fangjie Jiang; Qi Chen; Wei Wang; Yan Ling; Yan Yan; Pu Xia
Journal:  J Hepatol       Date:  2019-09-27       Impact factor: 25.083

2.  Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Authors:  Yuan Wang; Lian-Shun Jia; Wen Yuan; Zhao Wu; Hai-Bo Wang; Tao Xu; Jing-Chuan Sun; Ke-Fu Cheng; Jian-Gang Shi
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

3.  Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice.

Authors:  Lifang Lv; Nan Zheng; Lijia Zhang; Ruotong Li; Yingnan Li; Rui Yang; Chao Li; Ruonan Fang; Azaliia Shabanova; Xuelian Li; Yingqi Liu; Haihai Liang; Yuhong Zhou; Hongli Shan
Journal:  Eur J Pharmacol       Date:  2020-05-22       Impact factor: 4.432

4.  The expression significance of serum MiR-21 in patients with osteosarcoma and its relationship with chemosensitivity.

Authors:  Y Hua; Z Jin; F Zhou; Y-Q Zhang; Y Zhuang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-07       Impact factor: 3.507

Review 5.  The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.

Authors:  Liangliang Xu; Yanfang Zhang; Jianwei Tang; Peng Wang; Lian Li; Xiaokai Yan; Xiaobo Zheng; Shengsheng Ren; Ming Zhang; Mingqing Xu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-02       Impact factor: 4.254

6.  MicroRNA: Biogenesis, Function and Role in Cancer.

Authors:  Leigh-Ann Macfarlane; Paul R Murphy
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

7.  Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma.

Authors:  Junjie Niu; Yibao Sun; Qiaoge Guo; Dongju Niu; Bo Liu
Journal:  Springerplus       Date:  2016-11-09

8.  The microRNA cluster miR-17∼92 promotes TFH cell differentiation and represses subset-inappropriate gene expression.

Authors:  Dirk Baumjohann; Robin Kageyama; Jonathan M Clingan; Malika M Morar; Sana Patel; Dimitri de Kouchkovsky; Oliver Bannard; Jeffrey A Bluestone; Mehrdad Matloubian; K Mark Ansel; Lukas T Jeker
Journal:  Nat Immunol       Date:  2013-06-30       Impact factor: 25.606

9.  miR-34 inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression.

Authors:  Liang Xi; Yongfeng Zhang; Shengnan Kong; Wei Liang
Journal:  Biosci Rep       Date:  2018-06-12       Impact factor: 3.840

10.  Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.

Authors:  David S Hong; Yoon-Koo Kang; Mitesh Borad; Jasgit Sachdev; Samuel Ejadi; Ho Yeong Lim; Andrew J Brenner; Keunchil Park; Jae-Lyun Lee; Tae-You Kim; Sangjoon Shin; Carlos R Becerra; Gerald Falchook; Jay Stoudemire; Desiree Martin; Kevin Kelnar; Heidi Peltier; Vinicius Bonato; Andreas G Bader; Susan Smith; Sinil Kim; Vincent O'Neill; Muhammad S Beg
Journal:  Br J Cancer       Date:  2020-04-02       Impact factor: 7.640

View more
  9 in total

Review 1.  Role of autophagy in drug resistance and regulation of osteosarcoma (Review).

Authors:  Yanchuan Pu; Jin Wang; Shizhong Wang
Journal:  Mol Clin Oncol       Date:  2022-02-01

2.  Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy.

Authors:  Peng He; Shenglin Xu; Zehao Guo; Peng Yuan; Yulei Liu; Yu Chen; Tiantian Zhang; Yukang Que; Yong Hu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 3.  The basic characteristics of extracellular vesicles and their potential application in bone sarcomas.

Authors:  Shenglong Li
Journal:  J Nanobiotechnology       Date:  2021-09-17       Impact factor: 10.435

4.  Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma.

Authors:  Hua Liu; Chenyu Zong; Jiacheng Sun; Haiyang Li; Guangzhen Qin; Xiaojian Wang; Jianwei Zhu; Yang Yang; Qiang Xue; Xianchen Liu
Journal:  Transl Pediatr       Date:  2022-07

5.  Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.

Authors:  Kaniz Fatema; Zachary Larson; Jared Barrott
Journal:  Biocell       Date:  2022-06-13       Impact factor: 1.110

Review 6.  miRNA in Molecular Diagnostics.

Authors:  Maja Matulić; Paula Gršković; Andreja Petrović; Valerija Begić; Suzana Harabajsa; Petra Korać
Journal:  Bioengineering (Basel)       Date:  2022-09-09

7.  miR-486-5p Serves as a Diagnostic Biomarker for Sepsis and Its Predictive Value for Clinical Outcomes.

Authors:  Baobin Sun; Shubin Guo
Journal:  J Inflamm Res       Date:  2021-07-30

Review 8.  Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers.

Authors:  Guillaume Anthony Odri; Joëlle Tchicaya-Bouanga; Diane Ji Yun Yoon; Dominique Modrowski
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

9.  Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion.

Authors:  Lavinia Raimondi; Alessia Gallo; Nicola Cuscino; Angela De Luca; Viviana Costa; Valeria Carina; Daniele Bellavia; Matteo Bulati; Riccardo Alessandro; Milena Fini; Pier Giulio Conaldi; Gianluca Giavaresi
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.